Enteroviral Infections in the First Three Months of Life

Marcello Sandoni1, Lidia Ciardo1, Caterina Tamburini1

  • 1Pediatric Post-Graduate School, University of Modena and Reggio Emilia, 41125 Modena, Italy.

Insights

Enterovirus (EV) infections are common in infants and can be severe, particularly in newborns. Current treatments are supportive, highlighting the need for further research into effective antiviral therapies for severe EV cases.

Area of Science:

  • Virology
  • Pediatric Infectious Diseases
  • Molecular Epidemiology

Background:

  • Enteroviruses (EVs) are a significant cause of infection in children, especially neonates and infants.
  • The molecular epidemiology of EVs is vital for understanding serotype circulation due to their variability.
  • EV infections can range from mild to life-threatening, particularly in early infancy.

Purpose of the Study:

  • To review the current understanding of enterovirus infections in the pediatric population.
  • To highlight diagnostic methods and the clinical impact of severe EV infections.
  • To discuss the current supportive treatment and the need for antiviral research.

Main Methods:

  • Review of existing literature on enterovirus epidemiology, diagnosis, and treatment in children.
  • Analysis of clinical outcomes, including mortality and neurodevelopmental sequelae.
  • Evaluation of current diagnostic techniques, primarily PCR-based RNA detection.

Main Results:

  • Enterovirus infections are a major concern in pediatric populations, with neonates being highly vulnerable.
  • Severe infections can lead to critical conditions like myocarditis, hepatitis, and multi-organ failure, with potential long-term neurodevelopmental issues.
  • Current diagnostic methods rely on detecting viral RNA, and treatment remains largely supportive.

Conclusions:

  • Enterovirus infections pose a significant threat to infants, necessitating robust epidemiological surveillance.
  • While diagnosis is established, effective antiviral treatments for severe neonatal enterovirus infections require further investigation.
  • Additional studies are crucial to validate the efficacy of antiviral agents in clinical practice for severe cases.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
485
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.9K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.3K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K